UBS (Lux) Digital Health Equity Q Cap $

Rating and Score  (On 30/06/2026)
Rating
FIDA
Rating
ESG
***Some functions are not available in this version.***
Register for free to unlock functions
Static data
Name
UBS (Lux) Digital Health Equity Q Cap $
Typology
Funds and Sicav
ISIN Code
LU1683288424
Sicav
UBS (Lux) Inv. SICAV 2
Registration country
-
Country authorised for sale
Asset manager
Address
33A avenue J.F. Kennedy L-1855 Lussemburgo
Phone
Web site
FIDA Category
Assogestioni category
EFAMA Category
Equity Health Care
Priips
Yes
Official benchmark
100.00% - MSCI AC World
Start Date placement
14/12/2017
Search by currency
Usd - us dollar
Quotation currency
Usd - us dollar
Status
Active
Distribution policy
No
Total asset value at 30/07/2026
35.95 mln USD
Assets of portfolio as of 30/07/2026
444.80 mln USD
Documentation
Quotation evolution (From 28/07/2023 On 30/07/2026)
151.29
6.11
%
30/07/2026
Loading data
Quote
Quotation currency
Usd - us dollar
Quotation frequency
Daily
Last quotation
$151.29 (30/07/2026)
% change
+0.91%
Last Price in Euro
€131.83
Investment Objective
Health care cost to society has risen to levels which are no longer sustainable. This fund invests globally in innovative companies which are driving a revolution in the health care sector through the application of technology. The investment universe comprises three segments: Research & Development, Treatments and Efficiency. The fund invests in "pure-play" digital health companies, which are typically small to mid-sized. The portfolio manager is not tied to the benchmark in terms of investment selection or weight.The return of the fund depends primarily on equity market development and their exchange rate fluctuations, as well as dividend payments.
Tax system
PIR compliant
No
PEA compliant
No
PEA-PME compliant
No
Company registry
Asset manager
Phone
Web site
Address
33A avenue J.F. Kennedy L-1855 Lussemburgo
The data and information covered by the Service are for the exclusive internal use of the User and may neither be transferred to third parties, nor circulated, disclosed or allowed to be disclosed, nor used on external information systems, without the written consent of FIDA and, when necessary, of the information sources.
Logo FIDA